Anti-EGFR aptameric construct GR20HH for controllable delivery of doxorubicin into glioblastoma cells
- Authors: Ivanov B.M.1, Antipova O.M.1, Sliman Y.A.2,3, Samoylenkova N.S.2, Pronin I.N.2, Pavlova G.V.2,4,5, Kopylov A.M.1
-
Affiliations:
- Lomonosov Moscow State University
- Burdenko National Medical Research Center of Neurosurgery, Ministry of Healthcare of Russia
- Moscow institute of physics and technology, national research university
- Institute of Higher Nervous Activity and Neurophysiology of Russian Academy of Sciences
- Sechenov First Moscow State Medical University
- Issue: Vol 74, No 1 (2024)
- Pages: 100-108
- Section: ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ
- URL: https://rjsvd.com/0044-4677/article/view/652112
- DOI: https://doi.org/10.31857/S0044467724010107
- ID: 652112
Cite item